Randall C Schatzman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Randall C Schatzman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Randall C Schatzman. Randall C Schatzman is President and CEO in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Chief Executive Officer in Bolt Biotherapeutics, Inc. ($BOLT).
Latest Insider Trading Transactions of Randall C Schatzman
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Schatzman Randall C | Chief Executive Off ... | Buy | P | 20.00 | 1,500 | 30,000 | 1,500 | 0 to 1.5 K |
Feb 21 2018 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | A | 13.55 | 200,000 | 2,710,000 | 200,000 | |
Feb 13 2017 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 1.65 | 30,000 | 49,500 | 78,181 | |
Feb 13 2017 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 25.03 | 30,000 | 750,756 | 115,172 | 145.2 K to 115.2 K (-20.67 %) |
Feb 13 2017 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 1.65 | 30,000 | 49,500 | 145,172 | 115.2 K to 145.2 K (+26.05 %) |
Jan 31 2017 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | A | 20.40 | 275,000 | 5,610,000 | 275,000 | |
Jan 31 2017 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Grant | A | 20.20 | 404 | 8,161 | 115,172 | 114.8 K to 115.2 K (+0.35 %) |
Nov 09 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 1.65 | 10,000 | 16,500 | 108,181 | |
Nov 09 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 25.16 | 10,000 | 251,605 | 114,768 | 124.8 K to 114.8 K (-8.01 %) |
Nov 09 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 1.65 | 10,000 | 16,500 | 124,768 | 114.8 K to 124.8 K (+8.71 %) |
Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 1.27 | 8,181 | 10,349 | 0 | |
Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 31.55 | 2,700 | 85,189 | 114,768 | 117.5 K to 114.8 K (-2.30 %) |
Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 30.95 | 5,481 | 169,622 | 117,468 | 122.9 K to 117.5 K (-4.46 %) |
Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 1.27 | 8,181 | 10,349 | 122,949 | 114.8 K to 122.9 K (+7.13 %) |
Sep 06 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 1.27 | 10,000 | 12,650 | 8,181 | |
Sep 06 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 32.48 | 10,000 | 324,820 | 114,768 | 124.8 K to 114.8 K (-8.01 %) |
Sep 06 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 1.27 | 10,000 | 12,650 | 124,768 | 114.8 K to 124.8 K (+8.71 %) |
Aug 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 1.27 | 10,000 | 12,650 | 18,181 | |
Aug 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 32.69 | 16 | 523 | 114,768 | 114.8 K to 114.8 K (-0.01 %) |
Aug 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 31.68 | 4,816 | 152,570 | 114,784 | 119.6 K to 114.8 K (-4.03 %) |
Aug 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 30.65 | 5,168 | 158,420 | 119,600 | 124.8 K to 119.6 K (-4.14 %) |
Aug 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 1.27 | 10,000 | 12,650 | 124,768 | 114.8 K to 124.8 K (+8.71 %) |
Jul 27 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 1.27 | 10,000 | 12,650 | 28,181 | |
Jul 27 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 28.08 | 10,000 | 280,805 | 114,768 | 124.8 K to 114.8 K (-8.01 %) |
Jul 27 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 1.27 | 10,000 | 12,650 | 124,768 | 114.8 K to 124.8 K (+8.71 %) |
Jun 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 1.27 | 10,000 | 12,650 | 38,181 | |
Jun 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 30.26 | 1,965 | 59,460 | 114,768 | 116.7 K to 114.8 K (-1.68 %) |
Jun 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 29.51 | 8,035 | 237,084 | 116,733 | 124.8 K to 116.7 K (-6.44 %) |
Jun 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 1.27 | 10,000 | 12,650 | 124,768 | 114.8 K to 124.8 K (+8.71 %) |
May 24 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 1.27 | 4,017 | 5,082 | 48,181 | |
May 24 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 1.27 | 2,997 | 3,791 | 52,198 | |
May 24 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 1.27 | 2,986 | 3,777 | 55,195 | |
May 24 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 28.03 | 4,017 | 112,588 | 112,947 | 117 K to 112.9 K (-3.43 %) |
May 24 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 1.27 | 4,017 | 5,082 | 116,964 | 112.9 K to 117 K (+3.56 %) |
May 24 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 28.01 | 2,997 | 83,952 | 112,947 | 115.9 K to 112.9 K (-2.58 %) |
May 24 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 1.27 | 2,997 | 3,791 | 115,944 | 112.9 K to 115.9 K (+2.65 %) |
May 24 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 28.01 | 2,986 | 83,635 | 112,947 | 115.9 K to 112.9 K (-2.58 %) |
May 24 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 1.27 | 2,986 | 3,777 | 115,933 | 112.9 K to 115.9 K (+2.64 %) |
Apr 18 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 1.27 | 4,514 | 5,710 | 58,181 | |
Apr 18 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 1.27 | 5,486 | 6,940 | 62,695 | |
Apr 18 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 0.39 | 8,538 | 3,287 | 0 | |
Apr 18 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 0.39 | 11,462 | 4,413 | 8,538 | |
Apr 18 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 28.08 | 4,514 | 126,742 | 112,947 | 117.5 K to 112.9 K (-3.84 %) |
Apr 18 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 1.27 | 4,514 | 5,710 | 117,461 | 112.9 K to 117.5 K (+4.00 %) |
Apr 18 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 28.11 | 14,024 | 394,150 | 112,947 | 127 K to 112.9 K (-11.05 %) |
Apr 18 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 1.27 | 5,486 | 6,940 | 126,971 | 121.5 K to 127 K (+4.52 %) |
Apr 18 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 0.39 | 8,538 | 3,287 | 121,485 | 112.9 K to 121.5 K (+7.56 %) |
Apr 18 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 28.01 | 11,462 | 321,075 | 112,947 | 124.4 K to 112.9 K (-9.21 %) |
Apr 18 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 0.39 | 11,462 | 4,413 | 124,409 | 112.9 K to 124.4 K (+10.15 %) |
Feb 02 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | A | 24.18 | 236,500 | 5,718,570 | 236,500 | |
Jan 06 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 0.39 | 10,000 | 3,850 | 20,000 | |
Jan 06 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 31.95 | 2,020 | 64,546 | 111,579 | 113.6 K to 111.6 K (-1.78 %) |
Jan 06 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 31.35 | 7,980 | 250,201 | 113,599 | 121.6 K to 113.6 K (-6.56 %) |
Jan 06 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 0.39 | 10,000 | 3,850 | 121,579 | 111.6 K to 121.6 K (+8.96 %) |
Dec 03 2015 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 0.39 | 10,000 | 3,850 | 30,000 | |
Dec 03 2015 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 37.24 | 10,000 | 372,431 | 111,579 | 121.6 K to 111.6 K (-8.23 %) |
Dec 03 2015 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 0.39 | 10,000 | 3,850 | 121,579 | 111.6 K to 121.6 K (+8.96 %) |
Nov 04 2015 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 0.39 | 10,000 | 3,850 | 40,000 | |
Nov 04 2015 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 34.44 | 5,222 | 179,839 | 109,921 | 115.1 K to 109.9 K (-4.54 %) |
Nov 04 2015 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 33.40 | 1,400 | 46,765 | 115,143 | 116.5 K to 115.1 K (-1.20 %) |
Nov 04 2015 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 32.70 | 3,378 | 110,462 | 116,543 | 119.9 K to 116.5 K (-2.82 %) |
Nov 04 2015 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 0.39 | 10,000 | 3,850 | 119,921 | 109.9 K to 119.9 K (+9.10 %) |
May 28 2015 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 0.39 | 50,000 | 19,250 | 50,000 | |
May 28 2015 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 38.96 | 50,000 | 1,948,085 | 109,921 | 159.9 K to 109.9 K (-31.27 %) |
May 28 2015 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 0.39 | 50,000 | 19,250 | 159,921 | 109.9 K to 159.9 K (+45.49 %) |
Jan 28 2015 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | A | 28.23 | 130,000 | 3,669,900 | 130,000 | |
Jan 28 2015 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 28.71 | 63,578 | 1,825,165 | 109,921 | 173.5 K to 109.9 K (-36.64 %) |
Jan 28 2015 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 27.93 | 36,422 | 1,017,234 | 173,499 | 209.9 K to 173.5 K (-17.35 %) |
Jul 10 2014 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | A | 16.90 | 80,000 | 1,352,000 | 80,000 | |
May 09 2014 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | A | 10.00 | 90,909 | 909,090 | 90,909 |
Page: 1